Welcome to our dedicated page for Equifax SEC filings (Ticker: EFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Equifax Inc. (NYSE: EFX) is a global data, analytics, and technology company whose SEC filings provide detailed insight into its credit reporting, workforce solutions, and compliance businesses. Through its periodic reports and current reports, Equifax discloses information about its financial condition, results of operations, risk factors, and significant corporate events.
On this page, you can review Equifax’s U.S. Securities and Exchange Commission filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its data, analytics, and cloud technology strategy, global operations across 24 countries, and the performance of areas such as consumer credit information and workforce solutions. Current reports on Form 8-K, such as those filed to announce quarterly financial results, provide timely updates on material events affecting the company.
Investors and analysts can also use this page to access other key documents, including proxy materials related to governance and executive compensation and, where applicable, insider transaction reports on Form 4 that show purchases and sales of Equifax securities by directors and officers. These filings help explain how Equifax manages its role as one of the major U.S. credit bureaus and as a provider of employment verification, AML compliance, and cloud-based analytics solutions.
Stock Titan enhances these filings with AI-powered summaries that highlight important sections and clarify complex disclosures. Real-time updates from the SEC’s EDGAR system ensure that new Equifax filings, including 10-Ks, 10-Qs, 8-Ks, and Forms 3 and 4, are available quickly, while AI-generated insights help readers understand the implications of changes in strategy, risk disclosures, and capital allocation for EFX shareholders.
Equifax insider sale by EVP/CFO/COO. John W. Gamble Jr., Equifax (EFX) executive, sold 3,000 shares of Common Stock on 08/18/2025 at $247.35 per share under a pre-established Rule 10b5-1 trading plan adopted 05/14/2025. After the sale he beneficially owns 62,202 shares, which figure includes accrued dividend equivalent units reinvested into restricted stock units through the company’s last dividend payment date. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 08/20/2025.
Equifax, Incorporated (EFX) filing a Form 144 notifies a proposed sale of 8,797 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $2,199,425.95. The filing shows the shares to be sold on 08/20/2025. The shares were acquired by option with grant date 05/01/2023 and the acquisition/expected sale date listed as 08/20/2025, with payment in cash. Total shares outstanding reported are 123,797,380. The filer certifies no undisclosed material adverse information and provides standard Rule 144 representations.
Equifax (EFX) Form 144 notice reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services with an aggregate market value of $742,050. The shares represent restricted stock that vested and were acquired on 02/23/2024 as compensation from the issuer. The filing shows 123,797,380 shares outstanding and lists an approximate sale date of 08/18/2025 on the NYSE. The filer states there were no securities sold in the past three months and makes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.
Equifax Inc. (EFX) Form 144 filing: CEO Mark W. Begor has filed notice to sell up to 48,264 common shares through Fidelity Brokerage on or after 07/28/2025. At the last reported market price, the proposed sale is valued at $11.85 million. The filing lists 123,797,380 shares outstanding, so the planned disposition equals roughly 0.04 % of total shares.
The shares come from two prior equity awards:
- 20,304 shares vested as restricted stock on 05/04/2021 (non-cash compensation).
- 27,960 shares from options granted 02/21/2020 and exercised for cash on 07/28/2025.
No additional financial metrics, earnings data, or company guidance are included in this short-form notice; the document solely satisfies SEC requirements for advance disclosure of certain insider sales.